文献速递神经免疫

亚致死性少突胶质细胞损伤:多发性硬化中的可逆状态?

Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?
PubMed 文献 · Ann Neurol · 2017-06-02

该研究结合MS患者尸检组织原位分析与成人脑来源少突胶质细胞体外培养,发现少突胶质细胞远端突起变性及髓鞘内空泡形成早于髓鞘碎片化,体外代谢应激下突起回缩在临界时间点前可逆,提示早期MS病灶中现存少突胶质细胞所形成髓鞘可能被保护和恢复。

要点

  • 少突胶质细胞远端突起变性及髓鞘内空泡形成是MS病灶早期事件,早于巨噬细胞吞噬髓鞘碎片。
  • 体外代谢应激下少突胶质细胞突起回缩与糖酵解呼吸活性降低相关,且在临界时间点前可逆。
  • 后续细胞死亡不依赖caspase-3程序,最晚可逆时间点基因表达显示突起生长、髓鞘形成及代谢通路下调。

核心结论

  • 早期和进展期MS病灶中现存少突胶质细胞形成的髓鞘具有保护和潜在恢复的可能。

研究设计与样本

  • 对临床急性期和病理活动期MS病例的戊二醛固定薄切片进行原位分析。
  • 采用成人脑来源少突胶质细胞解离培养,以低营养/低糖代谢应激条件进行体外研究。

主要发现

  • 原位分析显示少突胶质细胞形态完整时髓鞘已出现一系列改变,包括内层胞质舌变性及髓鞘内空泡增大,可导致髓鞘径向断裂。
  • 仅在髓鞘碎片化确立后才发现吞噬髓鞘碎片的巨噬细胞。
  • 体外研究中少突胶质细胞突起回缩与糖酵解呼吸活性降低相关,且在临界时间点前可逆。
  • 后续细胞死亡不与caspase-3依赖性程序相关。
  • 最晚可逆时间点基因表达研究显示细胞突起生长、髓鞘形成及代谢活性相关通路表达降低。

临床怎么用

  • 提示对早期和进展期MS病灶中现存少突胶质细胞所形成髓鞘进行保护和恢复具有潜在治疗价值。
  • 需进一步研究成人少突胶质细胞后续死亡机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Degeneration of oligodendroglial distal processes has been identified as an early event in multiple sclerosis (MS) lesion development. Our objective was to further define the development of the "dying-back" oligodendrocyte lesion in situ and to model the development and potential reversibility of such responses using dissociated cultures of adult human brain-derived oligodendrocytes. METHODS: In situ analyses were performed on glutaraldehyde-fixed thin sections of clinically acute and pathologically active cases of MS. In vitro studies were conducted using adult human brain-derived oligodendrocytes challenged by metabolic stress conditions (low nutrient/glucose). RESULTS: In situ analyses indicated a spectrum of myelin changes in the presence of morphologically intact oligodendrocytes; these included degeneration of the inner cytoplasmic tongue with increasing sizes of intramyelinic bleb formation that could result in radial fractures of the myelin sheath. Macrophages with ingested myelin fragments were identified only once the fragmentation was established. In vitro studies indicated that oligodendrocyte process retraction, which was linked to reduced glycolytic respiratory activity, is reversible until a critical time point. Subsequent cell death was not linked to caspase-3-dependent programs. Gene expression studies conducted at the latest reversible time point revealed reduced expression of pathways associated with cell process outgrowth and myelination, as well as with metabolic activity. INTERPRETATION: Our findings reveal the potential to protect and possibly restore myelin elaborated by existent oligodendrocytes in early and evolving MS lesions, and suggest the necessity of ongoing studies of the mechanisms underlying subsequent adult human oligodendrocyte cell death. Ann Neurol 2017;81:811-824.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Cui QL, Khan D, Rone M, et al. Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis? Ann Neurol. 2017. PMID: 28470695. doi:10.1002/ana.24944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。